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7METHODOLOGY Open AccessBilateral uterine vessel ligation as a model of
intrauterine growth restriction in mice
Mathilde Janot1,2*, Marie-Laure Cortes-Dubly3, Stéphane Rodriguez1,2 and Uyen Huynh-Do1,2Abstract
Background: Intrauterine Growth Restriction (IUGR) occurs in up to 10% of pregnancies and is considered as a
major risk to develop various diseases in adulthood, such as cardiovascular diseases, insulin resistance, hypertension
or end stage kidney disease. Several IUGR models have been developed in order to understand the biological
processes linked to fetal growth retardation, most of them being rat or mouse models and nutritional models. In
order to reproduce altered placental flow, surgical models have also been developed, and among them bilateral
uterine ligation has been frequently used. Nevertheless, this model has never been developed in the mouse,
although murine tools display multiple advantages for biological research. The aim of this work was therefore to
develop a mouse model of bilateral uterine ligation as a surgical model of IUGR.
Results: In this report, we describe the set up and experimental data obtained from three different protocols (P1,
P2, P3) of bilateral uterine vessel ligation in the mouse. Ligation was either performed at the cervical end of each
uterine horn (P1) or at the central part of each uterine horn (P2 and P3). Time of surgery was E16 (P1), E17 (P2) or
E16.5 (P3). Mortality, maternal weight and abortion parameters were recorded, as well as placentas weights, fetal
resorption, viability, fetal weight and size. Results showed that P1 in test animals led to IUGR but was also
accompanied with high mortality rate of mothers (50%), low viability of fetuses (8%) and high resorption rate (25%).
P2 and P3 improved most of these parameters (decreased mortality and improved pregnancy outcomes; improved
fetal viability to 90% and 27%, respectively) nevertheless P2 was not associated to IUGR contrary to P3. Thus P3
experimental conditions enable IUGR with better pregnancy and fetuses outcomes parameters that allow its use in
experimental studies.
Conclusions: Our results show that bilateral uterine artery ligation according to the protocol we have developed
and validated can be used as a surgical mouse model of IUGR.
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Intrauterine growth restriction (IUGR) refers to a condition
in which a fetus is unable to reach its genetically
determined potential size. It can result in a baby being
Small for Gestational Age (SGA), the fetal weight being
below the 10th percentile for the gestational age. SGA
group also includes fetuses that are constitutionally but not
pathologically small. IUGR can either lead to symmetric
growth restriction, where fetal entire body is proportionally* Correspondence: m.janot@chu-nancy.fr
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unless otherwise stated.small, or asymmetric growth restriction, where growth of
vital organs such as the brain and heart is maintained at
the expense of the liver, muscle and fat consequently to
insufficient nutrient delivery. This state can evolve to
symmetric growth restriction, if the factor responsible for
growth restriction is severe or sustained long enough [1].
IUGR is thus a major cause of perinatal morbidity
and mortality [2], and is of high clinical relevance
since it represents up to 10% of all pregnancies [3].
This phenomenon corresponds to a fetal adaptation
to an inadequate supply of oxygen and/or nutrients.
Various studies have shown that an adverse uterine
environment may be a cause of diseases in adulthood,
such as hypertension, cardiovascular diseases, insulin
resistance or end stage kidney disease [4-7]; thus IUGRtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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Consequently, several animal models have been developed
to study the mechanisms of IUGR. Most of these studies
have been performed in rodents (principally in rats);
others implicated bigger animals such as sheep, pigs,
monkeys or lambs [8]. A widely used experimental model
consists in altering nutritional parameters during
pregnancy with caloric restriction, low protein diet or
iron deficiency [8]. This model is particularly interesting to
reproduce malnutrition conditions that are a major cause
of fetal growth retardation in the world. Other common
models consist in exposing pregnant animals to hypoxic
conditions [9] or surgical interventions, which themselves
lead to hypoxia by decreasing placental flow and thus affect
both placenta and fetus. These surgical models are relevant
to study human pregnancy in developed countries, where
altered placental flow is the main mechanism implicated
in IUGR [8].
The most frequently used surgical model corresponds
to bilateral uterine artery ligation in sheep, rabbits or
rats [8,10,11]. Ligation of uterine arteries is performed,
leading to ischemia. But despite its frequent experimental
use, this model shows several weaknesses. First, this
surgery is accompanied by high maternal mortality, fetal
resorption and variation in fetal weights [12,13]. More
importantly, a recent carefully performed study showed
experimentally that bilateral ligation of the uterine arteries
in rats didn’t reproducibly lead to IUGR, while a
meta-analysis of the literature indicated a bias in
publications where pups with IUGR were selected
[10]. As a consequence of the problems mentioned
above, (high rate of fetal resorption in smaller animal
species) there has been almost no studies using this
surgical technique in mouse, which is however the
most used animal model by the scientific community.
Notably, many genetic mouse models have been described
and constitute fundamental tools to understand several
biological and pathological mechanisms.
The aim of this study was therefore to set up and validate
a model of fetal growth retardation in pregnant C57BL6/J
mice induced by bilateral uterine vessel ligation. Pregnancy
outcomes parameters such as mortality, weight and abor-
tion were checked; fetal weight and size were measured, as
well as fetal resorption, viability and placentas weights. Our
results showed that bilateral uterine vessel ligation is indeed
an effective method to induce IUGR in the mouse model.
Methods
Animals
Pregnant C57BL6/J mice from Charles River France
laboratories were group-housed prior to surgery, then
housed in individual cages after surgery. Mating was
done in Charles River France laboratories and the
mating date (half day) was recorded precisely. Micewere maintained in 12 h light/dark cycles and allowed free
access to food and water and were then transferred to the
site of surgery in Charles River's laboratories. All animal
experiments were performed according to European and
Swiss Animal Welfare laws and were reviewed and
approved by the animal ethics committee from Charles
River Laboratories, France.
Surgery and study design
In order to set up the most suitable mouse model of
IUGR, chronologically three different protocols were
followed (P1, P2, P3 - Figure 1A). The design of P2 and
P3 was modified according to the results of P1 and P2
respectively, especially in terms of surgical technique
(ligation site and type of suture at ligation), analgesia
and time between surgery and termination. In P1,
surgery was performed on embryonic day 16 (E16) while
surgery from P2 and 3 were performed at E17 and
E16.5, respectively. E16.5 surgery was performed A.M
while E17 surgery was performed P.M. In P1, animals
received a pre-operative subcutaneous injection of an
analgesic buprenorphine (Buprecare®, 0.05 mg/kg) which
was associated by abdominal suture pulling out for
several mice. This phenomena was considered to be
associated with pruritus induced by buprenorphine use
(secondary effect already observed after subcutaneous
injection of buprenorphine in rats). In P2 and P3,
Flunixine meglumine (Finadyne®, 2.5 mg/kg), an analgesic
(NSAID) without any impact on pregnancy, was thus
chosen to replace buprenorphine. Animals then
underwent general anesthesia with isoflurane. A midline
laparotomy was performed in order to expose the uterine
horns and their vascularization, fetuses were counted and
surgery was performed (Figure 1A- C). At P1, ligation site
was chosen as described in the literature [11]. The ligation
(Vicryl 5–0 Ethicon®) of the uterine vessels (containing the
uterine artery and vein) was performed distally near the
cervical end of each uterine horn. This ligation induced a
significant reduction of the blood flow as the blood
flow from the iliac artery was completely stopped.
The consequence of this blood flow reduction was a
very low viability of the fetuses and a high rate of
partial abortion (defined as the pre-term loss and
expulsion of a fetus or embryo) in the test group. In
P2, ligation site was modified in order to obtain a
moderate blood flow reduction as compared with P1
and then a higher viability of the fetuses and lower
rate of partial abortion in the test group. The uterine
vessels were ligated in P2 and P3 at the central part
of each uterine horn (generally between fetus n°2 and
3 (P2 and P3, Figure 1B) so that the blood flow from
both the iliac and ovarian arteries was still existing.
The results of P2 confirmed this hypothesis: a higher
rate of fetus’ viability and a lower rate of partial
Figure 1 Description of the three protocols of bilateral uterine ligation experiments. A. Study scheme of the experiments. After
acclimatization, surgery was performed on pregnant mice at E16 (P1), E17 (P2) or E16.5 (P3). Fetuses were extracted before delivery, at E18.5,
preceding general observation, weighing, euthanasia and organ collection. B. Ligation localization. In P1, ligation was performed in test animals
around the distal part of the uterine vessels, near the cervical end of each uterine horn; in P2 and P3 ligation was performed in test animals
around the central part of each uterine horn, generally between fetus 2 and 3. Control animals underwent sham procedure. C. Number of
pregnant mice and fetuses (at surgery) used in the three different protocols. P, Protocol.
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suture (Vicryl in P1 and Ethibond in P2 and P3) was
modified in P2 and P3 to Ethibond 5–0, Ethicon® due
to surgical preferences. Control group animals underwent
sham procedure without ligation. After the uterus was
placed back into the abdominal cavity, animals received
Lidocaïne (Xylovet®, 3.5 mg/kg) at the incision site
(P1, administration of Lidocaïne before closure of the
abdominal wall; P2 and P3, the abdominal wall was
closed and animals received a subcutaneous injection
of Lidocaïne). Until complete recovery, oxygen was
delivered to females that were maintained on heating
pads and kept under close observation. An analgesic
subcutaneous injection of flunixine meglumine (Finadyne®,
2.5 mg/kg) (P2 and P3) or buprenorphine (Buprecare®,
0.05 mg/kg) (P1) was administered at the end of the day of
surgery and the next day. Females underwent caesarian
section at E18.5 and were then sacrificed.
Calculation of fetal resorption and viability rates
Fetal resorption rate was calculated as the number of
fetuses counted at the time of surgery minus the number
of fetuses found at E18.5 at the time of caesarian section.
Results are expressed as a percentage of fetuses counted
at the time of surgery. Fetal viability was calculated
from the total number of fetuses found at termination
(E18.5 – in the uterus or in the bedding). Viability
was evaluated using macroscopic parameters such as
coloration (normal pink/purple vs. brown, green, black),
body consistency (normal, dry or soft), size, or body
malformation. Data are presented as a percentage of
viable fetuses counted at termination.
Fetal weight, size measurements and tissue collection
On E18.5, animals underwent isoflurane anesthesia
and hysterectomy. Number and localization of fetuses in
each uterine horn was performed, dams were sacri-
ficed by pentobarbital intracardiac injection. Placentas
were collected and weighed. Size of the fetuses was calcu-
lated by multiplying the cranio-caudal and dorso-ventral
distances of the fetuses. After macroscopic observation
(viability, color, size) and weighing, fetuses underwent
euthanasia by decapitation. Kidneys, liver, spleen, hearts
and lungs were collected for further macroscopic observa-
tions including shape, coloration, consistency, differenti-
ation and presence of blood spots. Percentage of fetuses
with IUGR was calculated using the total number of
fetuses from control or test animals and the number
of fetuses meeting IUGR conditions (2 SD below the
mean weight of control fetuses).
Glomerular counting
Kidney tissue for estimation of glomeruli number was
fixed with 2% paraformaldehyde, embedded in paraffinand sectioned at 8 μm. Total number of glomeruli in a
total volume of 49,6 μm3 was estimated on FFPE kidney
sections stained with H&E following the physical
fractionator stereologic technique [14].
Statistics
Data are presented as mean ± SD. Unpaired t test based
on average per litter was used to analyze differences
observed between two groups. Data were considered
significant when P value < 0.05. Significance levels
were ***, P < 0.001; **, P < 0.005; *, P < 0.05. All statistics
were analyzed with the GraphPad Prism5 package.
Results
Follow-up of operated mice and pregnancy outcomes
The follow-up of operated animals until termination day
(E18.5) indicated major differences in pregnancy outcomes
depending on the considered protocol. Indeed, P1 was
associated with the most severe impact as all mice
from the test group presented some aborted fetuses
(partial abortion) (Figure 2). P2 presented better maternal
parameters with 43% of mice undergoing partial abortion,
while P3 showed an intermediate situation (75% of partial
abortion). Weight loss was also more severe in P1 and P3
than in P2 (Table 1), which nevertheless led to weight loss
in both test and control groups: in P2, test mice presented
a decrease of 18% of their weight over 1.5 day after surgery;
control mice also lost weight with a decrease of 6% but with
stabilization at the end of experiment (Table 1). In P1, test
animals lost around 21% of their body mass, in contrast to
what was observed in control animals which gained around
9% of their body mass over 2.5 days. Weight loss in test
animals from P3 was similar to what was observed in P1
with a decrease of 22%; control mice weight was stable with
an overall decrease of 1% (SD 3%) over 2 days but with an
increased weight after 1 day of surgery. On the termination
day (E18.5), macroscopic observations also showed the
impact of surgery on the uterus with abnormal colorations
of the surfaces of uterine horns in 57% (P1, P2) to 58% (P3)
of test animals (data not shown).
Fetal characteristics
Number of fetuses and fetal resorption
The number of fetuses was determined both at day of
surgery and day of extraction (E18.5) (Table 1); results
reflected the rate of abortion and resorption observed in
each protocol. In P1, the mean number of fetuses per
mouse (litter size) was identical in control animals (8)
and reduced in test animals (7 to 4). Similar results were
obtained in P2 (7 mean number of fetuses in control
animals vs. 7 to 6 fetuses found in test dams). In P3,
mean number of fetuses found at E18.5 was significantly
lower in test mice with 9 fetuses at D0 vs. 4 at termination.
Control conditions led to similar number of fetuses at
Figure 2 Study outlines from P1, P2 and P3. Study outlines from P1, P2 and P3 with number of animals used in each protocol and pregnancy
outcomes (p.a., partial abortion; p.d., partial delivery). Number and percentage of mice that presented some aborted fetuses (partial abortion) are
highlighted under each diagram; P1 was associated to the worst pregnancy outcomes.
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test mice. Fetal resorption was also precisely analyzed by
comparing the number of fetuses found at the day of
surgery and the number of fetus alive at E18.5. P3
presented the highest rate of fetal resorption with
37%, while P2 resorption rate was 0% (Table 1). P1
revealed an intermediate situation with 25% of global
fetal resorption. Control groups didn’t show any fetal
resorption.
Fetal viability
Fetal viability at termination day was also evaluated
using macroscopic observations such as coloration, body
consistency (normal, dry or soft), or body malformation
(Figure 3A-E). Majority of not viable animals corre-
sponded to resorbed fetuses (or in way of resorption)
which generally showed abnormal coloration (dark,
green vs. pink/purple), soft consistency and general body
malformation (Figure 3D); other not viable fetuses were
not resorbed but displayed abnormal consistency and
body malformation such as head malformation, body
length or absence of members (Figure 3C). As expected,
control groups were associated with high viability
rate (89.7 to 100%) and didn't show macroscopic
abnormalities of the fetuses while test groups presented
lower viability (Figure 3E). In P1 experiment, only 8%
of the test fetuses were viable, compared with 59%
for P2 and 27% for P3.Observation of fetal organs
Macroscopic observation of fetal organs (kidney, heart,
lung, liver) gave results in accordance with viability rates.
Organs from control fetuses from all protocols globally
didn't show macroscopic abnormalities, although
observation of organs from test animals showed defects
such as friable consistency, unusual coloration, blood
spots, malformation or visible lack of differentiation. Data
recorded for P2 and P3 (Figure 3E) showed that 46% (P3)
to 50% (P2) of test fetuses found at termination presented
such defects at different levels of severity compared to 7%
(P3) to 910% (P2) of control fetuses. Most of these defects
were visible on organs from non viable fetuses. In order to
explore the impact of ligation on organs from viable
fetuses, we observed kidneys from P3 control and test
fetuses that also presented higher weights than the
average. Glomeruli were counted and corresponding
data showed a tendency (P = 0.2) to a 10% decreased
number of glomeruli in kidneys from viable test fetuses
compared to control fetuses (Figure 3F).
Weight and size of fetuses
Weight and size of fetuses were measured in all experi-
mental groups and presented significant differences
between control and test animals in protocols P1 and P3
(Figure 4A-C). In P1, mean weight of test fetuses was
significantly lower than the values of control animals
(0.45 vs. 0.92 g, P < 0.05). Similar results were obtained
Table 1 Comparison of general parameters from P1, P2 and P3
Parameters P1 P2 P3
Ctrl Test Ctrl Test Ctrl Test
Pregnancy outcomes Weight monitoring + 9 −21 −6 −18 −1 −22
± 1% ± 5% ± 1% ±8% +/−3% +/−10%
Abortion 0% 100% 0% 43% 0% 75%
Mean number of fetuses
at surgery (D0*) 8 +/− 1 7 +/− 1 7 +/− 1 7 +/− 1 8 +/− 0 9 + −/ 1
at extraction (E18.5) 8 +/− 1 4 +/− 2 7 +/− 1 6 +/− 2 8 +/− 0 4 +/− 2
Fetal data Fetal resorption 0 25 0 0 0 37
(E18.5) +/− 0% +/−30% +/−0% +/−0% +/−0% +/−33%
Fetal viabiliy 92 8 90 59. 100 27
+/−6% +/−14% +/−7% +/−22% +/−0% +/−33%
Mean weight of fetuses 0.92 0.45 0.98 0.89 1.05 0.54
± 0.10 g ± 0.24 g ± 0.05 g ±0.08 g ± 0.04 g ± 0.21 g
IUGR? - Yes - No - Yes
Fetuses with IUGR 13% 73% 20% 37% 4% 61%
Mean fetal weight: Placental weight ratio 9.0 +/− 1.0 4.7+/−2.3 9.5+/1.6 10.2+/−1.9 9.8+/−0.2 7.0+/−1.9
Mean size of the fetuses 1.38 0.92 1.31 1.25 1.8 1.08
±0.29 cm2 ± 0.42 cm2 ±0.20 cm2 ±0.25 cm2 ±0.14 cm2 ±0.35 cm2
Mean weight of placentas 0.10 0.08 0.11 0.08 0.11 0.07
± 0.02 g ± 0.02 g ± 0.02 g ± 0.03 g ± 0.01 g ± 0.01 g
Pregnancy outcomes such as maternal weight and abortion showed that worst parameters were associated to P1 whereas P2 presented the best maternal
parameters. P3 had an intermediate situation. Fetuses were counted on day of surgery (D0) and on termination day (E18.5) in control and test animals; mean litter
size are presented. Fetal resorption rate is expressed as a percentage of fetuses counted at the time of surgery. Uterine artery ligation caused a significantly
increased rate of fetal resorption in test animals from P1 and P3. P1 corresponded to the worst fetal viability rate and P2 to the best rate. IUGR was effective in P1
and P3 where more than 50% of fetuses completed these conditions. Fetal weight : Placental weight ratios were significantly reduced in test animals from P1 and
P3. Measured fetal sizes were in accordance to recorded fetal weights with significant differences in P1 and P3. Placental weights were significantly reduced in all
protocols. * D0 = E16 for P1, E17 for P2 and E16.5 for P3.
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significant in P3 than in P1 (P < 0.005). Nevertheless, the
mean weights of fetuses in P2 didn’t reveal significant
differences between control and test groups (P = 0.21).
Thus, mean weight of test fetuses in P1 and P3 corre-
sponded to IUGR conditions (2 SD below the mean
weight of control fetuses), contrary to results of P2. In
addition, 73% and 61% fetuses were growth restricted in
P1 and P3, respectively, while only 37% were growth
restricted in P2 (Table 1).
Sizes of the fetuses were in accordance with the
measured weights: no significant reduction was observed
in P2, while decreased surfaces were observed for test
animals in P1 and P3, which also presented statistical
relevancy (P < 0.005 – Table 1 and Figure 4B).
Position of ligation and influence on weight
Weight of fetuses from P3 (which significantly led to
IUGR with good maternal and fetal viability characteristics)
was also observed according to their position in the uterus
in order to see the influence of ligation (Figure 5). Despite
the different number of fetuses from the different testanimals, fetal weight was decreased for fetuses placed after
ligation (generally between fetus n°2 and 3) (Figure 5B).
The same result was observed for placentas of the right
side of the uterus from test mice, although left test
placentas all showed a decreased weight (Figure 5C).
Weight and macroscopic observations of placentas
As IUGR is associated with placental insufficiency, we
also measured the weight of placentas at E18.5 (Figure 6).
Interestingly, all protocols led to differences in placental
weights, with P2 and P3 being associated with statistical
significance (P2, P < 0.05, P3, P < 0.005, Figure 6). This
was in accordance with reduced fetal weight and size in
P1 and P3 protocols. Interestingly, P2 was also associated
with a significantly reduced placental weight, although
mean fetal weight didn’t complete IUGR conditions. Mean
Fetal weight : Placental weight ratios (F/P) were calculated
as a measure of placental efficiency and IUGR. F/P ratios
were significantly reduced in test groups in P1 and
P3 (P < 0.05, Table 1), with the lowest values associated to
test animals in P1 (F/P =4.7). No significant differences
were observed in P2. Macroscopic observations also
Figure 3 Viability of fetuses found at extraction. A-D Macroscopic observation of fetuses. Examples of viable/non viable fetuses and
associated placentas are presented. A. Probably viable control fetus with pink/purple coloration and no visible malformation; B. Probably viable
test fetus with pink/purple coloration and no visible malformation; C. Not viable test fetus with soft consistency and body malformation; D. Not
viable resorbed test fetus. E. Mean fetal viability rates and macroscopic observation of organs. Mean fetal viability was assessed according to macroscopic
observation of fetuses and are presented as mean value of data obtained from the different mothers used in each protocol; test animals were associated
with lower viability rates. Macroscopic observation of the organs (kidney, liver, spleen, heart, lungs) was based on the following parameters : shape,
coloration, consistency, differentiation and presence of blood spots. Macroscopic organ defects were analyzed and recorded from all control and test
mice from each protocol ; * results from test mice from P1 are not presented as not relevant (only 7 fetuses were studied). Around 50% of test fetuses
from P2 and P3 presented organ defects. NA, Not applicable. F. Mean number of glomeruli from control and viable test kidneys in P3. Estimated number
of glomeruli in a total volume of 49,6 μm3 from P3 viable fetuses showed a tendency to decrease in test kidneys compared to control samples.
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ligation was indeed associated to a higher proportion of
placentas displaying macroscopic abnormal features such
as unusual coloration (white, brown, black vs. dark
red/pink) or lack of visible vascularization (Figure 6).
Macroscopic abnormalities were mostly observed in
placentas associated to non viable fetuses. In P1, 13%
of the test retrieved placentas displayed macroscopic
abnormalities vs. 4% in the control animals. In test animalsFigure 4 Weight and size of the fetuses found at termination. A. Weig
significantly reduced weight was observed in test animals from P1 and P3.
definition (2 SD below the mean weight of control fetuses). B. Size of cont
decreased surfaces for test animals in P1 and P3 were recorded.from P2 and P3, 57% and 58% of the placentas were
macroscopically abnormal, while only 0% to 16% of control
placentas were affected (Figure 6).
Discussion
Uterine artery ligation has long been used in large
animals’ models such as sheep, rabbits or larger rodents to
produce IUGR [8], nevertheless recent studies underline
the weaknesses of this method. Notably, uterine arteryht of control and test fetuses from all protocols were recorded,
Mean weight of test fetuses from P1 and P3 completed IUGR
rol and test fetuses from all protocols were measured and significantly
Figure 5 Influence of ligation position on fetal weight. A. Fetus
numbering according to position in the uterus. Fetuses are numbered
starting from the most caudal position in each uterine horn. R, right uterine
horn; L, left uterine horn. B. Mean fetal weight according to position in the
uterus in P3. More distal fetuses presented lower weights than caudal
fetuses. C. Mean placental weight according to position in the uterus in P3.
Placentas associated to distal fetuses presented lower weights in the right
uterine horn, data from left side didn’t show significant differences.
Janot et al. Reproductive Biology and Endocrinology 2014, 12:62 Page 8 of 11
http://www.rbej.com/content/12/1/62ligation results in high abortion rate of fetuses (at least
30%, [8,10,11] and IUGR is not necessarily demonstrated
[10]. Another problem of this commonly used surgical
technique is that in rodents it is mostly performed on rats
[8] and no studies have so far established it in mice. This
animal model is however widely used by the scientific
community, resulting in a huge availability of genetic
models that are invaluable tools to study biological
mechanisms and diseases. In the present study we
developed a model of bilateral uterine vessels ligation
in mice in order to study the biological mechanisms
associated to IUGR. We set up three different protocols in
order to obtain a model resulting in IUGR conditions with
similar or improved health and viability parameters than
what is usually observed in rodent bilateral uterine artery
ligation studies. We then designed three different
protocols with differences based on the position of
the ligation and on the day of surgery. In Protocol 1
(P1), early surgery was performed at E16 with ligation
around the cervical end of each uterine horn, while
in Protocol 2 (P2) and 3 (P3), ligation was performed
on E17 or 16.5 around the central part of each uterine
horn. Performing a distal ligation of the uterine vessels
near the cervical end of each uterine horn leads to a
complete blocking of the blood flow from the iliac artery.
The remaining blood flow comes only from the ovarian
arteries and is significantly reduced. On the contrary,
when performing a ligation of the uterine vessels at the
central part of each uterine horn, the blood flow from
both the iliac and ovarian arteries is still existing. The
restriction of blood flow is then lower than the one
induced by a distal ligation. The results we obtained
concerning both the follow-up of pregnant operated mice
and the weight of their fetuses underlined the importance
of surgery location and time-point parameters. As expected,
an earlier and more caudal surgery had a higher impact
on fetal weight, but this was also accompanied by
higher abortion rate and high mortality of the
mothers, with bad viability prognostic for the fetuses
(Table 1). In P1, which led to IUGR of the fetuses, we
indeed observed a strong impact of surgery on the health
status of test mice which led to death or euthanasia of
50% of them. We then improved our protocol by changing
ligation site and time of surgery. The resulting protocols
P2 and P3 gave much better results in terms of maternal
parameters, but only P3 was associated with IUGR of the
fetuses. Then, in P3, no prenatal maternal mortality was
described while fetal weight was significantly decreased.
Time of surgery itself has an important impact on the
health status of the operated mice, as indicated by the
weight differences observed between control animals.
Surgery had an important impact on mice health status, as
weight loss was observed for all the groups (test and control
from all protocols). Thus, in P2, a shorter recovery time
Figure 6 Macroscopic observations and weight of placentas. A-D Macroscopic observation of placentas: examples of placentas and
associated fetuses. A. Normal control placenta associated to a probably viable fetus with central red coloration and peripheral beige coloration;
vascularization is easily visible. B. Normal test placenta associated to a probably viable fetus with central red coloration and peripheral beige
coloration; vascularization is easily visible. C. Abnormal coloration of a test placenta with brown peripheral color, associated to a probably viable
fetus. D. Abnormal clear-pink colored placenta from a no viable test fetus. E. Placental abnormalities rates. Macroscopic placental defects were
calculated from all placentas from P1, P2, P3; test fetuses were associated to a higher rate of abnormal placentas than control ones in all protocols.
F. Mean weight of placentas from control and test animals in P1, P2, P3. Test placental weights were significantly reduced in all protocols.
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control pregnant mice, while control mice from P1
had more time to recover (2.5 days) which resulted in
a weight gain one day after surgery. In the same way,
control mice from P3 protocol started to gain weight
at the end of the experiment (two days after surgery).
For all protocols, control mice underwent a weight
loss just after surgery, thereafter they started to recover or
stabilize depending on the length of recovery. In this case,
early weight loss was slight and was not associated with
abortion. For test animals, all protocols led to a decreased
weight which was associated with ligation. Notably, P1
was associated with the biggest difference between control
and test animals, and was also associated with the worst
viability parameters. Such consequences are to be related
to ligation itself, as control animals from P1, which
underwent sham procedure, recovered. Weight loss of test
animals was comparable in all 3 protocols (−18 to −22%
of body mass, Table 1), and underlined the effect of
uterine artery ligation during pregnancy. This decrease
can notably be attributed to partial abortions and partial
deliveries observed in test groups, while weight loss from
control groups in P2 and P3 can be linked to short
recovery times after surgery. High weight loss and
mortality rate from P1 test animals led us to change our
protocol in P2 and P3 to a shorter experimental time.
Another important experimental point is the rate of
abortion encountered with uterine artery ligation, leading
to reduced litter size. Here, we report that all test micefrom P1 underwent partial abortion, while 75% test mice
from P3 did (Table 1), underlying strong impact of surgery
on mice from P1. In P2, no abortion was observed. In the
same way, P1 was accompanied by the highest resorption
rate, as opposed to P2. In this regard, P3 seems to be an
appropriate intermediate leading to IUGR while resulting
in similar resorption rates to what is observed with rat
model [10,11,15] and higher viability than P1 (Table 1).
Not surprinsingly, P2 presented the best viability rate.
Nevertheless, both abortion and resorption rates in P3 still
led to a significantly reduced number of fetuses found at
termination, representing a loss of 50% of fetuses, a
parameter that has to be taken into account to set up
further ligation experiment. In particular, results showed
variability in the resorption rate (Table 1). This was due to
the differences observed between test animals, with for
instance 2 animals having all fetuses resorbed while 4
didn't show any resorption. The differences in viability
data also show the differential impact of ligation at E18.5
depending on the protocol; the resulting viable fetuses can
be used to study the mechanisms and consequences of
IUGR after birth. Further studies could also take into
account the possible additional mortality that can occur
during labor in case of IUGR.
During pregnancy, placenta supplies maternal substrates
to the fetus and can adapt to the maternal environment
with changes in substrate delivery to the fetus [16]; it thus
plays an important role in fetal programming in utero and
placental weight is related to birth weight and fetal growth
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blood supply. All protocols illustrated this fact with lower
test placental weights following surgery and statistical
significance for P2 and P3. Due to less test animals
available in P1, results didn't reach our significance
threshold. Despite this observation, IUGR was not always
associated to a decreased placental weight, as P2 didn’t
reach these conditions (mean weight of test animals 2 SD
below the mean weight of control animals), which could
be due to the shorter exposition time to decreased blood
supply compared with the other protocols and in particular
P3 (E17 to E18.5 vs. E16.5 to E18.5). Thus, in P3, placental
weight was more significantly decreased than in P2, which
paralleled a higher impact on fetal growth and underlines
the influence of the placenta on birth weight [16]. In order
to study placental efficiency, F/P ratios were calculated as
they also constitute an important indication of IUGR. Our
results showed decreased F/P ratios in test groups from P1
and P3, with no significant differences in P2. These results
are in favor of placental insufficiency and IUGR in P1 and
P3. Indeed, a decrease in F/P ratio indicates that IUGR is
linked to a reduction of placental function per g of tissue
and increasing severity of IUGR has been shown to be
associated with increasing P/F ratio at comparable
gestational age (and thus decreasing F/P ratio) [18,19]. In
case of IUGR, placental size is affected before fetal size
and more resources are invested in fetal growth than in
placental growth. In our study, ligation occurs at late
gestation, when mouse fetuses are normally growing
most rapidly [20]. Thus, the impact of limitation is
very important and IUGR occurs when placental mass
per g of fetus becomes critical. In P1, in addition to a
distal position, ligation was made earlier than in other pro-
tocols, at E16. F/P ratios from test group in P1 are also the
lowest ones, while P2, which corresponded to the shortest
experimental time (ligation at E17), didn't present signifi-
cant differences. Only placental weights are decreased.
Nevertheless, the slight -but not significant- increase in F/P
ratio in P2 associated with the decreased placental weights
could suggest a better efficiency of these placentas to
maintain fetal growth. P3 had an intermediate situation
with an experimental duration leading to IUGR and a
decreased F/P ratio for test animals. As fetal growth is
more important at the end of gestation, the severity of the
impact of ligation increases with the duration of the
experiment. Delaying surgery from E16.5 to E17 thus leads
to IUGR and decreased efficiency of placentas in P3 and
not in P2. In addition, in test animals from all protocols,
ligation was associated to macroscopic abnormalities of
the placentas. This parameter reflects the impact of
surgery on placenta condition and efficiency and is related
to viability of the fetuses.
Impact of ligation and corresponding decreased blood
supply was also visible on test fetal organs (kidney, heart,lung, liver) that displayed macroscopic abnormalities. These
defects, such as malformations or lack of differentiation,
can be related to the consequences of IUGR and an adverse
uterine environment in adulthood as a risk factor for
several diseases such as hypertension, cardiovascular
problems, insulin resistance or end stage kidney disease.
As a consequence, additional data like weight of organs
could provide interesting information in order to further
characterize this IUGR model. In particular, this could
give information on the putative differential growth of
organs that can favor organs at the expense of others
that occurs in different cases of IUGR [1]. In our
study, macroscopic defects were mostly observed on
non viable fetuses (Figure 3). We thus also analyzed
the impact of ligation on the kidneys of viable fetuses by
counting glomeruli from P3 animals using morphometric
methods. We indeed observed a difference between the
number of glomeruli in test kidneys compared to control
organs. Due to the variability of this in vivo experiment, the
number of available animals, the technique used and the
fact that the analyzed fetuses had a higher weight than the
average, this result didn't reach our significance threshold
(P = 0.2 vs. P < 0.05), nevertheless it showed a clear
tendency towards a decreased number of glomeruli in
test kidneys (10%, Figure 3F) and thus a probable defect of
kidney differentiation. As nephrogenesis ends at D7 in
mice, this difference could be more important at the end
of this process.
Our experiment showed that uterine artery ligation was
effective to induce IUGR. Fetal weights were measured at
termination day E18.5 in order to avoid heterogeneity
resulting from different delivery time. Our data reveal
significantly decreased weights for fetuses from test
animals of P1 and P3 (Table 1). P1 presented the most
growth restricted fetuses, with mean weights of 0.45 g vs.
0.66 g for P3, but was also associated with the worst
pregnancy outcomes parameters. P2 led to tendencies of
growth restriction but without statistical significance
(Table 1). Not surprisingly, ligation position in P3 was
shown to influence the weight of fetuses depending on
their position in the uterus, which was also responsible for
variation in the recorded weights, although still lower than
control fetal data (Figure 5). Globally, placental and fetal
weights were not significantly different between left and
right horns. In P3, we ligated vessels in the central part of
each uterine horn, most often after fetus number 2. In the
right horn, placentas and fetuses situated after ligation
presented decreased weights compared to first fetuses. In
the left side, same tendency seemed to be observed for
fetuses, however experimental variations in small
weights made it hardly detectable for placentas. In normal
conditions, placental and fetal weight variations can be
observed depending on the number of fetuses in the horns
and their position. The larger the litter, the smaller each
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nutrients available for fetuses depends on the pressure
at which blood reaches the placenta. Less fetuses were
present in the left horn (mean 4 vs. 5, data not
shown), which could explain that placental and fetal
weights are somewhat more important than on the
right side, but the difference is not significant. Variations
in placental and fetal weights due to litter size and
position (due to blood gradient) are amplified by
ligation. Sizes of the fetuses also reflected intrauterine
growth restriction, with decreased surfaces for fetuses
from operated animals in P1 and P3.
Conclusions
This method of bilateral uterine ligation in mice is efficient
to induce IUGR. As a consequence, our study shows for
the first time the feasibility to use mice as a model of
IUGR/placental deficiency with the technique of bilateral
uterine ligation. Surgery according to the protocol P3
enables to study IUGR with good maternal parameters and
similar resorption and viability parameters to what is
observed in rat models. Thus, the novel surgical protocol
we established here paves the way to study molecular
mechanisms of IUGR and test various treatment options,
with the benefit of a huge availability of biological tools
dedicated to murine models.
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